ADAM17 and precursor B-cell acute lymphoblastic leukemia: The results demonstrated that the area under the curve of ADAM17 reached 0.989 and that of ATG3 reached 0.956 (Fig. 6D,E), thereby suggesting that these two proteins may represent valuable biomarkers of B-ALL.